|
|
Meeting Minutes:
Meeting minutes can be found in the meeting notes and resources folder on the National Safer Supply Community of Practice Google Drive.
March 3rd, 2022:
- Why "Safer Supply" instead of "Safe Supply"?
- Continuity of care
- Prescribing safer supply for individuals with benzodiazepine use disorder
March 10th, 2022:
- Equity and safer supply
- Is Diacetylmorphine available or accessible?
- Diverting and pregnancy – decreased Dilaudid and increased M-Eslon and Methadone
March 17th, 2022:
- Ontario province and healthcare
- Access to pharmaceuticals
- Withdrawal management
March 24th, 2022:
- Suppliers, their impacts on safer supply and working with them
- Police responses to overdose calls
- SUAP funding – how does payment work?
|
|
NSS-CoP Working Groups Currently Happening:
- Advisory Council: Meets monthly to provide input, feedback, and advice to the NSS-CoP team about the activities and direction of the NSS-CoP. We are currently seeking some clinical care members to join (RN, RPN, NP, MD). Next meeting: Wednesday, March 30th @ 2pm EDT.
- Reframing Diversion: The "issue of diversion" is often cited as a concern for people who are on the fence about or opposed to safer supply. This working group is challenging the dominant conception of diversion and producing some tools and documents to reframe the concept of diversion to reflect a more nuanced understanding about drug sharing/selling/etc., including that it often reflects a practice of care between people and the existence of unmet needs. The group has put together an FAQ document for prescribers that we will soon have finalized and ready to share. We are also looking at putting together an explainer video. Open to all members. Next meeting: Monday, April 11th @ 2pm EDT.
- People Who Use Drugs Working Group: This group was formed in January and includes about 18 members from different parts of the country, some who are on safer supply and some who are yet to be able to access safer supply. They are currently discussing some ideas of what work that they would like to do together. Members are compensated for their time. There is currently a waiting list to participate in this working group. Next meeting: Friday, April 22nd @ 1:30pm EDT.
- Pharmacist Meeting: We've had a couple of meetings with pharmacists to discuss safer supply from their perspectives and learn from them what challenges and successes that they have encountered, and see what tools/info might help support pharmacists to provide safer supply. There will be a pharmacist panel in April with some of the members from this group. Open to all pharmacists. Next meeting: Wednesday, April 20th @ 6:30pm EDT.
- Program Operations Meeting: Some folks involved with programming have started meeting to look at operations issues: policies, program needs, funding, etc. It's been interesting hearing about different programs and models, and the different contexts in which they operate. We are pooling resources, tools, templates, and knowledge products produced by programs to share with others to help make it easier for new programs to get going. Open to all program managers, coordinators. Next meeting: Friday, April 22nd @ 2pm EDT.
NSS-CoP Working Groups Coming in April and May 2022:
- Guidance for Withdrawal Management Services Providing Care to People on Safer Supply: We will have a small interdisciplinary group discuss suggested guidance and meet with some folks from WMS to hear what they might need as well.
- Securing Access to Pharmaceuticals: This is a big one - and as a working group we'll need to hone in on what we want to do together. The issue is the need to expand the range of medication options for safer supply. The challenge as a national group is that barriers to access are, in large part (but not only) regional/provincial.
- Pain Management Guidance: This group will look at developing some guidance to support health care providers to provide effective pain management to people who are on safer supply.
- Providing Carries: Thanks to Nat K. for suggesting a working group on this! This group will provide safer supply prescribers with guidance to support them to provide carries to people who are on safer supply.
- Models for Rural and Remote Communities: These communities face challenges to the models that are currently offered in urban settings. This group will meet to discuss the challenges and look for innovative and feasible solutions.
If you are interested in participating in any of these working groups, please email us at info@nss-aps.ca.
|
|
- Early Findings from Safer Supply Pilot Projects: In 2020, the Substance Use and Addictions Program at Health Canada funded ten time-limited safer supply pilot projects in three provinces. Health Canada then contracted a four-month qualitative assessment, from December 2020 to March 2021, of these projects to capture early learnings, including effective strategies for program delivery. This is a summary of an independent assessment report prepared by Dale McMurchy Consulting based on information gathered through surveys and interviews with safer supply program leads, staff and participants. While this assessment was funded by Health Canada, the information summarized herein does not necessarily represent the views of Health Canada.
- Petition: Drug Policies are Killing People: Over 25,000 Canadians have died since 2016 due to the poisoned drug supply. We have it in our power to prevent these deaths right now! Moms Stop The Harm (MSTH) is requesting your support for Bill C-216, An Act to amend the Controlled Drugs and Substances Act and implement a National Strategy on Substance Use.
- Safer Supply Roundtable - Beyond Medical Models: When MSTH co-founders Leslie McBain and Petra Schulz first met with Carolyn Bennett, the Federal Minister of Mental Health and Addictions and Associate Minister of Health, they discussed the importance of developing scalable models for safe supply. When the Minister offered that she would attend a round table on the topic if they were to organize one, they immediately jumped at the opportunity and reached out to the Canadian Drug Policy Coalition to help them organize and host.
- Harm Reduction: Last Week Tonight with John Oliver: John Oliver discusses why overdoses in the U.S. have been on the rise and what we should, and shouldn’t, be doing to prevent them.
- Crackdown - Episode 30: DULF: There is a brand-new Crackdown Podcast episode available titled "DULF". Here is a brief description of the episode: "In spite of a massive spike in overdose death, BC’s government still refuses to offer a genuinely safe supply of drugs. Eris Nyx and Jeremy Kalicum tell the story of how the Drug User Liberation Front has stepped up to do what the policymakers refuse to do themselves: offer people a safe version of the drugs they already use. Then, Crackdown’s science advisor, Professor Ryan McNeil talks about his recently published work on BC’s 'risk mitigation guidelines'. Why has this program failed to curb overdose deaths, and what needs to be done to improve it?"
|
|
RESEARCH PAPER OF THE MONTH
|
|
|
Lew, B. et al. 2022. The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study | Harm Reduction Journal
Highlights:
- There was a significant reduction in the non-fatal overdose rate after the safer drug use and safer supply harm reduction program was introduced.
- Pre-existing relationships between shelter providers, harm reduction groups, and healthcare providers were critical to implementing the program.
- This is a promising approach to reducing harms from the criminalization of substance use in congregate settings, particularly in populations with a higher prevalence of substance use and substance use disorders.
Have a question that you’d like to ask? Email us: safersupplyon@gmail.com or send a message via Twitter, Instagram, Facebook.
|
|
We encourage NSS-CoP members to email safersupplyon@gmail.com with submissions to include in our newsletter. Content examples include but are not limited to community-led projects, peer-reviewed articles, grey literature, government publications, etc.
-
Nataraj, N., et al. 2022. Dose Tapering, Increases, and Discontinuity among Patients on Long-Term High-Dose Opioid Therapy in the United States, 2017-2019 | Drug and Alcohol Dependence
-
Gomes, T., et al. 2022. Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario | Ontario Drug Policy Research Network
- Gomes, T., et al. 2022. Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: A population-based propensity-score matched cohort study | Addiction
- Godkhindi, P., et al. 2022. “They're Causing More Harm than Good.” A Qualitative Study Exploring Racism in Harm Reduction Through the Experiences of Racialized People Who use Drugs | Harm Reduction Journal
- Reed, M. K., et al. 2022. “You can't go wrong being safe”: Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs | International Journal of Drug Policy
- Nassau, T., et al. 2022. Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada | Harm Reduction Journal
- Biondi, B. E., et al. 2022. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community | Addiction Science & Clinical Practice
- Khair, S., et al. 2022. Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study | Harm Reduction Journal
- Landreat, M. G., et al. 2022. How do people who use drugs receiving Opioid Medication Therapy perceive their treatment? A multicentre study | Harm Reduction Journal
- Hodges, J., et al. 2022. Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown | Addiction Science & Clinical Practice
-
Pivovarova, E., et al. 2022. Legislatively Mandated Implementation of Medications for Opioid Use Disorders in Jails: A qualitative study of clinical, correctional, and jail administrator perspectives | Drug and Alcohol Dependence
-
Bennett, A. S., et al. 2022. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City | Harm Reduction Journal
-
O'Keefe-Markman, C., et al. 2022. The Current State of Psychostimulants Use and Harms in Canada | Canadian Journal of Addiction
-
Sedney, C. L., et al. 2022. “The DEA would come in and destroy you”: a qualitative study of fear and unintended consequences among opioid prescribers in WV | Substance Abuse Treatment, Prevention, and Policy
-
Government of Canada. 2021. Modelling opioid-related deaths during the COVID-19 outbreak
-
Bruneau, A., et al. 2022. French-Canadian Translation and Cultural Adaptation of the Clinical Opiate Withdrawal Scale: The COWS-FC | Canadian Journal of Psychiatry
-
O'Reilly, K., et al. 2022. Distinguishing personal use of drugs from drug supply: Approaches and challenges | International Journal of Drug Policy
-
Schiff, D. M., et al. 2022. “You have to take this medication, but then you get punished for taking it:” lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period | Journal of Substance Abuse Treatment
-
Samples, H., et al. 2022. Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes | Journal of Substance Abuse Treatment
-
Williams, A. R., et al. 2022. Non–prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder | Journal of Substance Abuse Treatment
-
Larnder, A., et al. 2022. Variability in the unregulated opioid market in the context of extreme rates of overdose | Drug and Alcohol Dependence
|
|
National and General News:
British Columbia:
Alberta:
Saskatchewan:
Manitoba:
Ontario:
Yukon:
Québec (et en français s'il vous plaît!):
Maritimes (Nova Scotia, New Brunswick, Prince Edward Island, Newfoundland):
International:
|
|
|
|
|
|